NeoPharm (Korea) Overlap Studies MESA Adaptive Moving Average
| 092730 Stock | KRW 11,950 10.00 0.08% |
| Symbol |
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to NeoPharm LTD price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
NeoPharm Technical Analysis Modules
Most technical analysis of NeoPharm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NeoPharm from various momentum indicators to cycle indicators. When you analyze NeoPharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NeoPharm Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NeoPharm LTD. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeoPharm LTD based on widely used predictive technical indicators. In general, we focus on analyzing NeoPharm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeoPharm's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NeoPharm's intrinsic value. In addition to deriving basic predictive indicators for NeoPharm, we also check how macroeconomic factors affect NeoPharm price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeoPharm in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeoPharm's short interest history, or implied volatility extrapolated from NeoPharm options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 40 shares | |
 | Automobiles and Trucks Invested over 50 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Macroaxis Index Invested few shares | |
 | Social Domain Invested few shares | |
 | Impulse Invested few shares | |
 | FinTech Invested few shares | |
 | Electronic Equipment Invested few shares | |
 | Investing Invested few shares | |
Other Information on Investing in NeoPharm Stock
NeoPharm financial ratios help investors to determine whether NeoPharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NeoPharm with respect to the benefits of owning NeoPharm security.